Middle East and Africa Defibrillator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Implantable Cardioverter Defibrillator and External) and End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings,

Middle East and Africa Defibrillator Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Implantable Cardioverter Defibrillator and External) and End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities)

The defibrillator market in the Middle East & Africa is expected to grow from US$ 529.01 million in 2021 to US$ 688.80 million by 2028; it is estimated to grow at a CAGR of 3.8% from 2021 to 2028. Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality. Unhealthy lifestyles and habits, including tobacco consumption, poor diet, obesity, physical inactivity, and excess alcohol consumption, are the leading causes of CVDs. The surging cases of CVDs result in high demand for defibrillators as an essential tool for resuscitation and care of CVD patients in hospitals. With a rise in national healthcare expenditures and disposable household incomes in various regions, the use of defibrillators is expected to increase further to manage CVDs better. Furthermore, amid such high demands for defibrillators as a vital instrument in hospitals, automated external defibrillators are gaining special traction due to their suitability in the resuscitation of a person having a sudden cardiac arrest (SCA). Thus, the growing incidence of CVDs drives the demand for defibrillators of all types in hospitals, homes, and other healthcare settings.

The increasing number of COVID-19 cases and poor healthcare infrastructure, especially in Africa, has put a massive strain on the healthcare industry. The Middle East & Africa saw an increase in demand for defibrillators as an essential device for the care of COVID-19 patients but the lack of supply in the region by local players and demand from other regions for defibrillators adversely affected the market. Donations from other regions and supply from companies outside the region aided in the demand for defibrillators in the region but fell short, especially in Africa.

Based on end user, the Middle East & Africa defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities. The hospitals and clinics segment held the largest share of the market in 2020. Hospitals and clinics are the largest entities that have all the facilities available in the organization. They also provide various diagnostics and treatments facilities that can be reimbursed under the insurance claims. Hospitals have all the required equipment and instruments, such as defibrillators. Due to the development in the healthcare facilities hospitals are upgraded with modernized equipment and are installed with digital pathology and artificial intelligence. These technologies assist in communicating within the interdepartments and performs the auto procedure with precision. Hospitals are associated with various doctors, specialists’ doctors, and other professionals that provide better healthcare services. Rise in cardiac arrest cases, the growing number of cardiac implant procedures, and the availability of reimbursements across developed markets are driving the hospital and clinics segment market growth.

The overall Middle East & Africa defibrillator market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the Middle East & Africa defibrillator market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants involved in this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the Middle East & Africa defibrillator market. Abbott; Boston Scientific Corporation; Koninklijke Philips N.V.; Medtronic; Nihon Kohden Corporation; Shenzhen Mindray Biomedical Electronics Co., Ltd; and ZOLL MEDICAL CORPORATION are among the key players operating in the Middle East & Africa defibrillator market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa Defibrillator Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Defibrillator Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Defibrillator Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution